Last week, Saniona announced that its partner Medix in Mexico had not received regulatory approval for tesofensine. In a new update, Saniona clarifies that Medix, as the primary applicant and manager of the approval process in Mexico, is actively engaging with the regulatory agency to resolve the matter.

Read the article at biostock.se:

https://www.biostock.se/en/2024/11/saniona-provided-a-tesofensine-update/

This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se/